KLOW certificate of analysis: one purity figure for a four-peptide blend
Research context reviewed 30 October 2026The KLOW certificate of analysis on PEPTALIAS lists 99.1% purity by HPLC for the finished 80 mg blend, batch KLOW-2026-438, against a minimum of 98.5%, and the vial costs A$169.99 on 30 October 2026. That one figure cannot establish the identity or quantity of GHK-Cu, BPC-157, TB-500 or KPV individually.
Prices on this page are list prices, and the product page always shows today's price.
This page explains what that number does and does not tell you, then compares the blend price with four single vials. PEPTALIAS products are supplied for lawful research use only, not for human or veterinary use.
KLOW price against the four single vials
| Product | Vial | Price | In stock |
|---|---|---|---|
| KLOW blend | 80 mg | A$169.99 (A$2.12 per mg) | Yes |
| GHK-Cu | 50 mg | A$69.99 | Yes |
| BPC-157 | 10 mg | A$79.99 | Yes |
| TB-500 | 10 mg | A$109.99 | Yes |
| KPV | 10 mg | A$69.99 | No |
The four singles would cost A$329.96, so the blend saves A$159.97 on the same labelled amounts; A$2.12 per mg covers the whole blend, not KPV alone. The comparison uses listed prices and labelled amounts, not a tested equivalence.
What is in a KLOW vial
| Component | Amount |
|---|---|
| GHK-Cu | 50 mg |
| BPC-157 | 10 mg |
| TB-500 | 10 mg |
| KPV | 10 mg |
| Total | 80 mg |
The same four amounts appear on the product page and in the supplier PDF; 80 mg is their sum, not 80 mg of each. Choosing the blend over singles is a choice of material, not a claim that combining them works better.
KLOW report at a glance
| Report field | Printed detail |
|---|---|
| Issuer | HK Qiangtai Technology Co., Ltd. |
| Product | KLOW 80 mg, 10 vials per box |
| CAS number | No single CAS number printed |
| Batch number | KLOW-2026-438 |
| Manufacture date | 4 July 2026 |
| Expiry date | 4 July 2028 |
| Purity (HPLC) | 99.1% against at least 98.5% |
| Loss on drying | 1.3% against at most 3.0% |
| Sterility | Sterile, by filtration |
The footer calls the document a reference template for customer consultation, so KLOW-2026-438 is the batch printed on the reference sheet, not a lot number tied to the vial you order. There are no heavy metal, microbial or endotoxin rows. The full PDF is published as received.
One purity figure is not four component tests
HPLC reports the share of the trace assigned to the main material. The supplier reference document prints one HPLC purity result of 99.1%; it does not explain how the four components were resolved or establish their individual identities or quantities. Loss on drying of 1.3% is weight lost on heating: water plus other volatile material. If component amounts matter to your work, ask us for a component-resolved assay from the supplier before ordering.
Some blend reports in the range do give separate results, among them the Wolverine report (BPC-157 99.2%, TB-500 98.8%) and the CJC-1295 + Ipamorelin report (99.1% and 98.9%), so a single figure is a feature of this document, not of every blend.
Why buy KLOW from PEPTALIAS
One vial at A$169.99 replaces four purchases totalling A$329.96 at listed prices and is the in-stock PEPTALIAS listing that contains KPV. PEPTALIAS publishes a certificate of analysis for every batch it stocks where one exists, and for KLOW that is the 99.1% report for KLOW-2026-438, shown with its single purity figure and missing component tests stated, not glossed over. Order on the product page with that limitation in view. The blends versus single peptides guide gives the background, and every other supplier report sits on the certificate of analysis hub.
Frequently asked questions
What purity does the KLOW COA show?
99.1% by HPLC for the finished 80 mg powder, batch KLOW-2026-438, against a printed minimum of 98.5%.
Does the KLOW COA give a purity for each peptide?
No. It gives one figure for the whole blend and no separate test of any component's identity or weight.
Is KLOW the same as GLOW?
No. The KLOW supplier PDF describes KLOW as GLOW plus 10 mg of KPV. The GLOW listing is 70 mg per vial with its component breakdown unconfirmed, so treat them as different products with separate reports.
Can I buy KPV on its own instead?
The KPV 10 mg vial is listed at A$69.99 but out of stock on 30 October 2026, so KLOW, a four-component mixture, is the PEPTALIAS listing in stock that contains KPV.